perfosfamide has been researched along with Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, JM; Eby, LL; Noga, SJ; Schepers, KG | 1 |
| Bagnara, GP; Bonsi, L; Bregni, M; Di Nicola, M; Magni, M; Massimo Gianni, A; Peccatori, F; Siena, S; Strippoli, P | 1 |
| Davidson, NE; Davis, JM; Jones, RJ; Kennedy, J; Marcellus, DC; Piantadosi, S; Rowley, SD; Wiley, JM; Wingard, JR; Yeager, AM | 1 |
| Ohira, M | 1 |
| Berd, D; Maguire, H; Mastrangelo, MJ | 1 |
| Flesch, M; Hervé, P | 1 |
2 review(s) available for perfosfamide and Neoplasms
| Article | Year |
|---|---|
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
Topics: Antineoplastic Agents; Blood Cells; Blood Component Transfusion; Blood Transfusion, Autologous; Bone Marrow Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Drug Resistance; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Neoplasms; Radiotherapy; Recombinant Proteins | 1993 |
The immunoaugmenting effects of cancer chemotherapeutic agents.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antineoplastic Agents; Cyclophosphamide; Humans; Hypersensitivity, Delayed; Immune Tolerance; Lymphocytes; Mice; Neoplasms; Neoplasms, Experimental; T-Lymphocytes, Regulatory | 1986 |
4 other study(ies) available for perfosfamide and Neoplasms
| Article | Year |
|---|---|
Comparison of progenitor cell concentration techniques: continuous flow separation versus density-gradient isolation.
Topics: Adult; Bone Marrow Cells; Bone Marrow Purging; Breast Neoplasms; Cell Count; Cell Separation; Centrifugation, Density Gradient; Child; Cyclophosphamide; Erythrocyte Count; Hematocrit; Hematopoietic Stem Cells; Humans; Indicators and Reagents; Neoplasms; United States; United States Food and Drug Administration | 1993 |
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Count; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Female; Granulocytes; Hematopoiesis; Hematopoietic Stem Cells; Humans; Infant; Kinetics; Male; Middle Aged; Neoplasms; Transplantation, Autologous | 1991 |
[Autologous bone marrow transplantation in pediatric cancer].
Topics: Adolescent; Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Evaluation Studies as Topic; Female; Humans; Male; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Autologous | 1990 |
[Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Separation; Centrifugation, Density Gradient; Cyclophosphamide; Graft vs Host Disease; Humans; Lectins; Leukemia; Lymphocyte Depletion; Methylprednisolone; Neoplasms; Neprilysin; Pilot Projects; Plant Lectins; Ricin; Soybean Proteins; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1986 |